Back to Search
ZAHEEN RABBANI, MD
MD
Anesthesiology Physician
NPI: 1417483702IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
MD61284892(WA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer.
PMID 19235531·Med Oncol·2010
8-other
Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
PMID 19591920·Free Radic Biol Med·2009
7-preclinical
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.
PMID 18365198·Cancer Chemother Pharmacol·2009
7-preclinical
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer.
PMID 19578493·Biomark Insights·2008
8-other
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.
PMID 19033663·J Clin Invest·2008
7-preclinical
Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
PMID 18411002·Int J Radiat Oncol Biol Phys·2008
7-preclinical
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.
PMID 17912235·Mol Ther·2008
7-preclinical
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.
PMID 17236973·Int J Radiat Oncol Biol Phys·2007
7-preclinical
Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.
PMID 17712313·Br J Cancer·2007
7-preclinical
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
PMID 17579721·PLoS One·2007
7-preclinical
NF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis.
PMID 17560552·Biochem Biophys Res Commun·2007
8-other
Temporal onset of hypoxia and oxidative stress after pulmonary irradiation.
PMID 17448873·Int J Radiat Oncol Biol Phys·2007
7-preclinical
Using biological markers to predict risk of radiation injury.
PMID 17395039·Semin Radiat Oncol·2007
6-review
Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.
PMID 17957541·Free Radic Res·2007
4-observational
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
PMID 16505109·Mol Cancer Ther·2006
7-preclinical
Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation.
PMID 17178846·Cancer Res·2006
7-preclinical
Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation.
PMID 17003785·Br J Cancer·2006
7-preclinical
H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity.
PMID 16855294·Nucleic Acids Res·2006
7-preclinical
Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation.
PMID 16751069·Int J Radiat Oncol Biol Phys·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 325 9TH AVE
SEATTLE, WA 98104 - Phone
- (206) 520-5000
Quick Facts
- NPI
- 1417483702
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile